Drug Pipeline

CLN-978 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in…		 Trial sites expanded: 17 -> 20 locations
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07041099 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… Sjögren Recruiting
NCT06994143 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… Rheumatoid Arthritis (RA Recruiting
NCT06613360 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… SLE Recruiting
Sponsors Running CLN-978 Trials
Cullinan Therapeutics Inc. (3)
Disease Areas
Lupus (SLE) (1) Rheumatoid Arthritis (1)
Get alerts when CLN-978 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free